Today's Wound Clinic – Near Infrared Spectroscopy & Predicting the Likelihood of Future Wound Healing

The SnapshotNIR device is an example of the rapidly emerging digital imaging assessment tools available to wound care providers for the management of chronic wounds. By establishing the condition of the wound bed and surrounding tissues, clinicians can actually predict whether or not a vascular component is influencing wound closure. Using this device, one can predict, up to one week in advance, that necrosis or dehiscence of a flap is probable.

This was featured on Today’s Wound Clinic website.

About SnapshotNIR:

ACTIONABLE, ACCURATE DATA

THE POWER OF DIAGNOSTIC-DRIVEN WOUND CARE IS IN YOUR HANDS

Chronic wounds are a health problem with significant reductions in quality of life and can have devastating consequences such as limb amputations and premature death. Current diagnostic tools to assess tissue health are either costly or difficult to employ (or both), and visual assessment alone is not adequate to see the whole picture. Historically there have been no easy or cost-effective ways to directly assess tissue viability. SnapshotNIR is a medical imaging device that visualizes and maps tissue oxygen saturation in the capillary network.

SnapshotNIR has features that expand the application of near-infrared spectroscopy (NIRS) to include imaging on almost all skin tones, advancing tissue assessment for physicians and patients. The device measures tissue oxygen saturation (StO2), oxyhemoglobin and deoxyhemoglobin in nearly all individuals at any location on the body. With the unique Hemoglobin View, providers can track the wound healing trends, to ensure that oxyhemoglobin increases, while deoxyhemoglobin decreases.

About Kent Imaging
Kent Imaging, located in Calgary, Alberta, Canada, is a leading innovator in near-infrared tissue oxygenation imaging, which develops, manufactures, and markets medical technology that supports real-time decision-making in wound care, vascular and surgical subspecialties. Kent holds multiple patents in oxygen imaging technology and continues to provide innovative and advanced diagnostic imaging solutions to aid healthcare systems nationally and internationally. SnapshotNIR is supported by clinical evidence demonstrating its ability to help improve clinical decision-making in wound care and reduce healing time. Since receiving FDA and Health Canada clearance in 2017, the technology has been featured in several published articles and peer-reviewed posters. Applying the knowledge gained from clinical trials to patient care promotes consistency of treatment and optimal outcomes.